Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury EBITDA Loss For Q3 Narrows To SEK 5.7 Mln

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    09/07/2025 07:06
    July 9 (Reuters) - Newbury Pharmaceuticals AB NEWBRY.ST:

NET REVENUE FOR Q3 INCREASES TO 6,686 TKR

EBITDA LOSS FOR Q3 NARROWS TO -5,691 TKR

Source text: ID:nMFN47Nc4l

Further company coverage: NEWBRY.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Newbury Pharmaceuticals AB

    See all news